Showing results (1821-1830 of 1,996) with videos related to

Sort By:
Pageof 200
Endocrine-Related Cancer|October 5, 2017
TERT structural rearrangements in metastatic pheochromocytomasTrisha Dwight, Aidan Flynn, Kaushalya Amarasinghe, et al.
The American Journal of Surgical Pathology|September 29, 2015
Eosinophilic, Solid, and Cystic Renal Cell Carcinoma: Clinicopathologic Study of 16 Unique, Sporadic Neoplasms Occurring in WomenKiril Trpkov, Ondrej Hes, Michael Bonert, et al.
The American Journal of Surgical Pathology|March 23, 2010
Immunohistochemistry for SDHB divides gastrointestinal stromal tumors (GISTs) into 2 distinct typesAnthony J Gill, Angela Chou, Ricardo Vilain, et al.
Multiple Sclerosis and Related Disorders|December 6, 2021
Diffusely abnormal white matter in clinically isolated syndrome is associated with parenchymal loss and elevated neurofilament levelsI M Vavasour, P Becquart, J Gill, et al.
The Journal of Pathology|April 4, 2017
Cousins not twins: intratumoural and intertumoural heterogeneity in syndromic neuroendocrine tumoursAidan Flynn, Trisha Dwight, Diana Benn, et al.
BMJ Open|October 25, 2022
Canadian infants presenting with Brief Resolved Unexplained Events (BRUEs) and validation of clinical prediction rules for risk stratification: a protocol for a multicentre, retrospective cohort studyNassr Nama, Parnian Hosseini, Zerlyn Lee, et al.
Chemistry & Biology|February 27, 2013
Discovery of wall teichoic acid inhibitors as potential anti-MRSA β-lactam combination agentsHao Wang, Charles J Gill, Sang H Lee, et al.
The American Journal of Surgical Pathology|June 26, 2013
BRAFV600E immunohistochemistry facilitates universal screening of colorectal cancers for Lynch syndromeChristopher W Toon, Michael D Walsh, Angela Chou, et al.
Pathology|July 4, 2017
Lessons learnt from implementation of a Lynch syndrome screening program for patients with gynaecological malignancyFedaa Najdawi, Ashley Crook, Jayne Maidens, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|September 3, 2020
A MXI1-NUTM1 fusion protein with MYC-like activity suggests a novel oncogenic mechanism in a subset of NUTM1-rearranged tumorsChristopher R McEvoy, Holly Holliday, Niko Thio, et al.
Pageof 200